Stock Scorecard



Stock Summary for Accelerate Diagnostics Inc (AXDX) - $1.75 as of 11/20/2024 7:47:40 PM EST

Total Score

7 out of 30

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for AXDX

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for AXDX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for AXDX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for AXDX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for AXDX (18 out of 90)

Stock Price Rating (Max of 10) 2
Historical Stock Price Rating (Max of 10) 9
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 2
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 3
Price to Earnings (Max of 10) 0

Latest News for for AXDX

Accelerate Diagnostics ( AXDX ) Reports Q3 Loss, Lags Revenue Estimates 11/7/2024 10:40:00 PM
Inari Medical, Inc. ( NARI ) Reports Q3 Loss, Tops Revenue Estimates 10/28/2024 9:55:00 PM
Texas Biomedical Research Institute enters landmark partnership with Coalition for Epidemic Preparedness Innovations 10/28/2024 8:09:00 PM
Optical Imaging Market Size to Reach USD 5.61 Billion by 2033 | Straits Research 10/10/2024 1:20:00 PM
Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System 10/1/2024 4:12:00 PM
Accelerate Diagnostics ( AXDX ) Completes WAVE Pre-Clinical Trial 8/14/2024 2:05:00 PM
Accelerate Diagnostics ( AXDX ) Reports Q2 Loss, Misses Revenue Estimates 8/8/2024 9:45:00 PM
Silk Road Medical ( SILK ) Reports Q2 Loss, Tops Revenue Estimates 8/7/2024 10:10:00 PM
InspireMD, Inc. ( NSPR ) Reports Q2 Loss, Misses Revenue Estimates 8/6/2024 1:25:00 PM
Delcath Systems, Inc. ( DCTH ) Reports Q2 Loss, Tops Revenue Estimates 8/5/2024 9:10:00 PM

Financial Details for AXDX

Company Overview

Ticker AXDX
Company Name Accelerate Diagnostics Inc
Country USA
Description Accelerate Diagnostics, Inc., an in vitro diagnostic company, offers solutions for diagnosing serious infections in the United States, Europe, and the Middle East. The company is headquartered in Tucson, Arizona.
Sector Name LIFE SCIENCES
Industry Name LABORATORY ANALYTICAL INSTRUMENTS
Most Recent Quarter 9/30/2024
Next Earnings Date N/A

Stock Price History

Last Day Price 1.75
Price 4 Years Ago 75.80
Last Day Price Updated 11/20/2024 7:47:40 PM EST
Last Day Volume 60,456
Average Daily Volume 58,600
52-Week High 5.23
52-Week Low 0.73
Last Price to 52 Week Low 139.73%

Valuation Measures

Trailing PE N/A
Industry PE 27.34
Sector PE 40.32
5-Year Average PE -21.44
Free Cash Flow Ratio 2.11
Industry Free Cash Flow Ratio 102.40
Sector Free Cash Flow Ratio 27.97
Current Ratio Most Recent Quarter 1.50
Total Cash Per Share 0.83
Book Value Per Share Most Recent Quarter -1.36
Price to Book Ratio 0.00
Industry Price to Book Ratio 800.29
Sector Price to Book Ratio 20.88
Price to Sales Ratio Twelve Trailing Months 3.68
Industry Price to Sales Ratio Twelve Trailing Months 3.81
Sector Price to Sales Ratio Twelve Trailing Months 7.11
Analyst Buy Ratings 1
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 25,043,800
Market Capitalization 43,826,650
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.64%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 1.43%
Reported EPS 12 Trailing Months -2.59
Reported EPS Past Year -2.00
Reported EPS Prior Year -2.15
Net Income Twelve Trailing Months -53,427,000
Net Income Past Year -61,600,000
Net Income Prior Year -62,493,000
Quarterly Revenue Growth YOY 2.20%
5-Year Revenue Growth -27.76%
Operating Margin Twelve Trailing Months -2.88

Balance Sheet

Total Cash Most Recent Quarter 20,900,000
Total Cash Past Year 13,200,000
Total Cash Prior Year 45,600,000
Net Cash Position Most Recent Quarter -80,115,000
Net Cash Position Past Year -60,456,000
Long Term Debt Past Year 73,656,000
Long Term Debt Prior Year 56,413,000
Total Debt Most Recent Quarter 101,015,000
Equity to Debt Ratio Past Year -0.37
Equity to Debt Ratio Most Recent Quarter -0.92
Total Stockholder Equity Past Year -19,888,000
Total Stockholder Equity Prior Year -22,264,000
Total Stockholder Equity Most Recent Quarter -48,481,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -27,500,000
Free Cash Flow Per Share Twelve Trailing Months -1.10
Free Cash Flow Past Year -41,231,000
Free Cash Flow Prior Year -49,282,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.02
MACD Signal 0.03
20-Day Bollinger Lower Band 1.14
20-Day Bollinger Middle Band 1.66
20-Day Bollinger Upper Band 2.19
Beta 0.60
RSI 49.48
50-Day SMA 1.66
150-Day SMA 8.08
200-Day SMA 24.72

System

Modified 11/20/2024 6:40:15 PM EST